{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:33:22Z","timestamp":1759775602276,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jaad.2016.04.059","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T10:18:47Z","timestamp":1471429127000},"page":"595-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome"],"prefix":"10.1016","volume":"75","author":[{"given":"Nicholas F.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc R.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennie T.","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhua","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Dias-Santagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Angelica","family":"Selim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith T.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai P.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.04.059_bib1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/modpathol.2015.39","article-title":"Mutational dichotomy\u00a0in desmoplastic malignant melanoma corroborated by multigene panel analysis","volume":"28","author":"Jahn","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2016.04.059_bib2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.2011.196","article-title":"Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal","volume":"25","author":"Miller","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2016.04.059_bib3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/ng.3382","article-title":"Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway","volume":"47","author":"Shain","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2016.04.059_bib4","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1038\/onc.2009.164","article-title":"Functional RET G691S polymorphism in cutaneous malignant melanoma","volume":"28","author":"Narita","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2016.04.059_bib5","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1535-7163.MCT-10-0901","article-title":"Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies","volume":"10","author":"Schramm","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jaad.2016.04.059_bib6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/jclinpath-2013-202127","article-title":"Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomaker","volume":"67","author":"Lade-Keller","year":"2014","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaad.2016.04.059_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/modpathol.2012.188","article-title":"Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I\/II melanoma","volume":"26","author":"Nielsen","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2016.04.059_bib8","first-page":"2509","article-title":"Tumor cell adhesion as a risk factor for sentinel lymph node metastasis in primary cutaneous melanoma","volume":"10","author":"Meyes","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2016.04.059_bib9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ:\u00a025 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jaad.2016.04.059_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/emmm.201000070","article-title":"Rapid targeted mutational analysis of human tumors: a clinical platform to guide personalized cancer medicine","volume":"2","author":"Dias-Santagata","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jaad.2016.04.059_bib11","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing. Available from: URL: http:\/\/www.R-project.org\/ Accessed July 26, 2015."},{"key":"10.1016\/j.jaad.2016.04.059_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1245\/ASO.2005.03.022","article-title":"Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma","volume":"12","author":"Hawkins","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2016.04.059_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0560.2008.01058.x","article-title":"Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis","volume":"36","author":"George","year":"2009","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jaad.2016.04.059_bib14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1067\/mjd.2000.109282","article-title":"Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma","volume":"43","author":"Henrique","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.04.059_bib15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1600-0560.2011.01704.x","article-title":"Incidence and survival of desmoplastic melanoma in the United States, 1992-2007","volume":"38","author":"Feng","year":"2011","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jaad.2016.04.059_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2133.2005.06462.x","article-title":"Desmoplastic malignant melanoma: a systematic review","volume":"152","author":"Lens","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.04.059_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/DAD.0b013e3181716e6b","article-title":"Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases","volume":"30","author":"De Almeida","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2016.04.059_bib18","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1002\/cncr.23895","article-title":"Desmoplastic neurotropic melanoma: clinicopathologic analysis of 128 cases","volume":"113","author":"Chen","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2016.04.059_bib19","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/01.pas.0000141391.91677.a4","article-title":"Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors","volume":"28","author":"Busam","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2016.04.059_bib20","doi-asserted-by":"crossref","first-page":"e0119716","DOI":"10.1371\/journal.pone.0119716","article-title":"Clinicopathologic predictors of survival in patients with desmoplastic melanoma","volume":"10","author":"Han","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2016.04.059_bib21","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1002\/cncr.25148","article-title":"Prognostic factors in cutaneous desmoplastic melanoma","volume":"116","author":"Murali","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2016.04.059_bib22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/cup.12186","article-title":"Immunohistochemical expression of p16 in desmoplastic melanoma","volume":"40","author":"Blokhin","year":"2013","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2016.04.059_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.humpath.2006.02.013","article-title":"Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanoma","volume":"37","author":"Attis","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaad.2016.04.059_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1755-148X.2009.00660.x","article-title":"High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma","volume":"23","author":"Goto","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2016.04.059_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jaad.2016.04.059_bib26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1067\/mjd.2001.110067","article-title":"Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: different correlation according to thickness","volume":"44","author":"Moretti","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.04.059_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2559.1996.d01-558.x","article-title":"p53-Protein and Ki-67 antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin","volume":"30","author":"Vogt","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/j.jaad.2016.04.059_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijc.2910640109","article-title":"The mutational status of p53 in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents","volume":"64","author":"Nabeya","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2016.04.059_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00008390-200209000-00007","article-title":"Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes","volume":"12","author":"Ragnarsson-Olding","year":"2002","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2016.04.059_bib30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/modpathol.2013.162","article-title":"A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma","volume":"27","author":"Weissinger","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2016.04.059_bib31","first-page":"1845","article-title":"Loss of nuclear p16 expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma","volume":"6","author":"Straume","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2016.04.059_bib32","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human nevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2016.04.059_bib33","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/ijc.21608","article-title":"p16 Expression\u00a0in primary malignant melanoma is associated with prognosis and lymph node status","volume":"118","author":"Mihic-Probst","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2016.04.059_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/CMR.0b013e32834defd6","article-title":"The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma","volume":"22","author":"Barr","year":"2012","journal-title":"Melanoma Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216301980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216301980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:38:22Z","timestamp":1759271902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216301980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0190962216301980"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.04.059","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.04.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}